Prescription of glucose-lowering drugs in women and men with type 2 diabetes
| Drug | Women (N=40 339) | Men (N=29 162) | P value |
| Metformin | 63.6 | 66.2 | <0.001 |
| Sulfonylurea | 13.1 | 13.3 | <0.001 |
| DPP-4 inhibitors | 26.9 | 29.9 | <0.001 |
| SGLT2 inhibitors | 11.1 | 15.6 | <0.001 |
| GLP-1RAs | 9.7 | 9.7 | 0.998 |
| Other oral drugs | 5.9 | 6.5 | 0.004 |
| Insulin | 46.9 | 47.1 | <0.001 |
Data are percentages unless otherwise specified.
DPP-4, dipeptidyl peptidase-4; GLP-1RA, glucagon-like peptide 1 receptor agonist; SGLT2, sodium glucose cotransporter 2.